Incidence Rate of Herpes Zoster Ophthalmicus: A Retrospective Cohort Study from 1994 through 2018.
Journal
Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
05
09
2019
revised:
25
09
2019
accepted:
01
10
2019
pubmed:
2
11
2019
medline:
19
6
2020
entrez:
1
11
2019
Statut:
ppublish
Résumé
To analyze the incidence rate (IR) of herpes zoster ophthalmicus (HZO) and differences by age, gender, race, and region from 1994 through 2018. Retrospective, observational cohort study. Patients with a new International Classification of Diseases, Ninth or Tenth Edition, codes for herpes zoster (HZ) and HZO from January 1, 1994, through December 31, 2018, in the OptumLabs Data Warehouse (OptumLabs, Cambridge, MA). OptumLabs Data Warehouse, a longitudinal, real-world data asset with de-identified administrative claims and electronic health record data, was used to identify enrollees with continuous enrollment in the database for 365 days or more. Patients with no history of HZ or HZO and a new code for HZ and HZO were counted as incident cases. The IR of HZO was calculated by year, 10-year age groups, gender, race, and region. Differences in IR from 1994 through 2018 by 10-year age groups and gender. From 1994 through 2018, 633 474 cases of HZ were reported, with 49 745 (7.9%) having HZO. The incidence of HZO increased from 1994 through 2018 by an estimated 1.1 cases per 100 000 person-years annually (95% confidence interval [CI], 1.0-1.3; P < 0.001). The estimated relative increase was 3.6% annually (95% CI, 3.0%-4.1%). HZO IR increased in all ages over 10 years until 2007, then began declining in individuals younger than 21 and older than 60, stabilizing in individuals 21 to 30 years old, and increasing more slowly among individuals 31 to 60 years old. Men showed an HZO incidence rate ratio (IRR) of 0.74 compared with women. Compared with white patients, the IRRs were 0.70, 0.75, and 0.64 for Asians, black patients, and Hispanics, respectively. The incidence of HZO has increased 3.6% per year from 1994 to 2018 in the United States. Since 2008, HZO incidence declined in individuals younger than 21 years and older than 60 years while increasing at a lower rate in middle-aged adults. Given the continued increase, greater efforts should be made to vaccinate eligible adults 50 years of age and older. More research on earlier vaccination is warranted.
Identifiants
pubmed: 31668889
pii: S0161-6420(19)32108-6
doi: 10.1016/j.ophtha.2019.10.001
pmc: PMC7039739
mid: NIHMS1544015
pii:
doi:
Types de publication
Journal Article
Observational Study
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
324-330Subventions
Organisme : NEI NIH HHS
ID : R01 EY028739
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Références
Mayo Clin Proc. 2007 Nov;82(11):1341-9
pubmed: 17976353
Clin Infect Dis. 2019 Jul 2;69(2):341-344
pubmed: 30496358
JAMA Ophthalmol. 2013 Mar;131(3):396-8
pubmed: 23494045
Am J Public Health. 2010 Jun;100(6):1116-22
pubmed: 20075320
Clin Infect Dis. 2019 Jul 2;69(2):345-347
pubmed: 30496366
Pediatr Infect Dis J. 2009 Nov;28(11):954-9
pubmed: 19536039
BMC Infect Dis. 2015 Nov 06;15:502
pubmed: 26546419
MMWR Surveill Summ. 2017 May 05;66(11):1-28
pubmed: 28472027
Clin Exp Ophthalmol. 2010 Dec;38(9):845-50
pubmed: 20572824
Ophthalmology. 2016 Jul;123(7):1469-75
pubmed: 27067924
MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):103-108
pubmed: 29370152
Medicine (Baltimore). 1982 Sep;61(5):310-6
pubmed: 6981045
MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4
pubmed: 18528318
Cornea. 2015 May;34(5):535-40
pubmed: 25710509
Clin Infect Dis. 2019 Apr 24;:
pubmed: 31147680
Am J Med. 2017 Jan;130(1):21-26
pubmed: 27644149
J Infect Dis. 2008 Mar 1;197 Suppl 2:S224-7
pubmed: 18419401
Br J Ophthalmol. 2016 Mar;100(3):312-4
pubmed: 26178905
Ophthalmology. 2008 Feb;115(2 Suppl):S3-12
pubmed: 18243930
Vaccine. 2005 May 9;23(25):3349-55
pubmed: 15837242
Am J Prev Med. 2017 Mar;52(3):362-372
pubmed: 27720342
Epidemiol Infect. 2002 Dec;129(3):593-7
pubmed: 12558343
Pediatrics. 2019 Jul;144(1):
pubmed: 31182552
JAMA Ophthalmol. 2016 Sep 1;134(9):1001-6
pubmed: 27387135
J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S130-5
pubmed: 18021864
Clin Infect Dis. 2016 Jul 15;63(2):221-6
pubmed: 27161774